TE1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bio-Techne Corp

Watchlist Manager

Watchlist

Price: 49.8 EUR Market Closed

Market Cap: €11.8B

B	Bio-Techne Corp XBER:TE1	US
N	Novartis AG DUS:NOT	CH
N	Nintendo Co Ltd DUS:NTO	JP
D	Dollarama Inc F:DR3	CA
	Roche Holding AG LSE:0TDF	CH
	Verrica Pharmaceuticals Inc NASDAQ:VRCA	US
	Emerita Resources Corp XTSX:EMO	CA
	Gateley (Holdings) PLC F:5I2	UK
C	Carter's Inc SWB:HCH	US
	Palantir Technologies Inc LSE:0A7R	US
	Cbrain A/S CSE:CBRAIN	DK
	Credit Agricole SA PAR:ACA	FR
	Volvo AB OTC:VOLAF	SE
Z	Zurich Insurance Group AG XBER:ZFI1	CH
C	Corcept Therapeutics Inc XBER:HTD	US
O	Owens Corning F:O5Q	US
D	Dongfang Electric Corp Ltd XBER:DEU	CN
C	Canopy Growth Corp NASDAQ:CGC	CA

Profitability Summary

Bio-Techne Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Declining Gross Margin

68% > 67%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

23%

Declining Operating Margin

25% > 23%

Low Net Margin

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

24% > 7%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

19%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.